Focal Point Pharmaceuticals, Inc. — Form D/A
Focal Point Pharmaceuticals, Inc. of MEMPHIS, TN, a company, filed a Form D amendment with the SEC on 2017-01-31. The offering totals $80K, of which $80K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-01-31
- Form: D/A
- Accession: 0001584237-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $80K
- Amount sold: $80K
- Investors: 2
- Date of first sale: 2017-01-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-279676
Issuer
- Name: Focal Point Pharmaceuticals, Inc.
- CIK: 0001584237
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 40 S. MAIN ST., MEMPHIS, TN, 38103
- Phone: 484-680-5222
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Raymond Hage | Director | Memphis, TN |
| Gary Prosterman | Director | Memphis, TN |
| Gary Stevenson | Director | Chicago, IL |
| Raymond Hage | Executive Officer | Memphis, TN |
| Gary Prosterman | Executive Officer | Memphis, TN |
Other filings by this issuer (2)
More